Grant opportunity · PAR-25-040
Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)
Who can apply (as listed)
- Public housing authorities / Indian housing authorities
- Small businesses
- State governments
- Public and state-controlled institutions of higher education
- Nonprofits without 501(c)(3) status (other than institutions of higher education)
- City or township governments
- Nonprofits with 501(c)(3) status (other than institutions of higher education)
- County governments
- Private institutions of higher education
- Special district governments
- Native American tribal organizations (other than federally recognized governments)
- Independent school districts
- For-profit organizations (other than small businesses)
- Others (see the opportunity text)
- Native American tribal governments (federally recognized)
Although the majority living with schizophrenia and related disorders are over 35 years old, including those first diagnosed and those aging with the illness, the mechanisms underlying the generation and trajectory of the illness remain poorly understood. The purpose of this initiative is to advance translational research to better understand the emergence and trajectory of schizophrenia and related disorders in mid to late life, and to identity targets for future development of prevention and treatment efforts.
Excerpt as published. The full synopsis, required forms, and any amendments are on the official listing.
GrantSet indexes public records and is not the official application channel. Responses and applications go through Grants.gov only — the official notice there controls if anything shown here differs.